• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性免疫缺陷病患儿中延长 VDPV 感染的自然清除。

Natural Clearance of Prolonged VDPV Infection in a Child With Primary Immunodeficiency Disorder.

机构信息

ICMR-National Institute of Virology, Mumbai Unit, Formerly Enterovirus Research Centre, Indian Council of Medical Research, Mumbai, India.

ICMR-National Institute of Immunohaematology, Indian Council of Medical Research, KEM Hospital, Mumbai, India.

出版信息

Front Immunol. 2019 Jul 23;10:1567. doi: 10.3389/fimmu.2019.01567. eCollection 2019.

DOI:10.3389/fimmu.2019.01567
PMID:31396204
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6663979/
Abstract

The emergence of immunodeficiency-associated vaccine-derived polioviruses (iVDPV) from children with primary immunodeficiency disorders poses a threat to the eradication program. Herein, we report a patient with severe combined immunodeficiency (SCID), identified as a prolonged serotype 3 iVDPV (iVDPV3) excreter with 13 VDPV3 isolates and a maximum of 10.33% nucleotide divergence, who abruptly cleared infection after a period of 2 years. Occurrence of an episode of norovirus diarrhea associated with increased activated oligoclonal cytotoxic T cells, inverse CD4:CD8 ratio, significantly elevated pro-inflammatory cytokines, and subsequent clearance of the poliovirus suggests a possible link between inflammatory diarrheal illness and clearance of iVDPV. Our findings suggest that in the absence of B cells and sufficiently activated T/NK cells, macrophages and other T cells may produce auto-inflammatory conditions by TLR/RLR ligands expressed by previous/ongoing bacterial or viral infections to clear VDPV infection. The study highlights the need to screen all the patients with combined immunodeficiency for poliovirus excretion and intermittent follow-up of their immune parameters if found positive, in order to manage the risk of iVDPV excretion in the polio eradication endgame strategy.

摘要

免疫缺陷相关疫苗衍生脊灰病毒(iVDPV)由原发性免疫缺陷患儿产生,对消灭脊灰病毒计划构成威胁。本研究报告了 1 例严重联合免疫缺陷(SCID)患儿,该患儿被鉴定为持续性 3 型 iVDPV(iVDPV3)排泄者,携带 13 株 iVDPV3 分离株,核苷酸差异最大达 10.33%,在经历 2 年的持续排泄后,病毒感染突然清除。诺如病毒腹泻发作,同时伴有激活的寡克隆细胞毒性 T 细胞增加、CD4:CD8 比值倒置、促炎细胞因子显著升高,随后脊灰病毒被清除,这提示炎症性腹泻病与 iVDPV 清除之间可能存在关联。本研究结果表明,在缺乏 B 细胞和充分激活的 T/NK 细胞的情况下,巨噬细胞和其他 T 细胞可能通过 TLR/RLR 配体产生自身炎症状态,从而清除 VDPV 感染,这些配体由先前/正在进行的细菌或病毒感染表达。该研究强调,在消灭脊灰病毒终局战略中,需要对所有联合免疫缺陷患儿进行脊灰病毒排泄筛查,并对检测阳性者的免疫参数进行间歇性随访,以管理 iVDPV 排泄风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef0/6663979/02e0853bcfcd/fimmu-10-01567-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef0/6663979/8a0d3284572d/fimmu-10-01567-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef0/6663979/02e0853bcfcd/fimmu-10-01567-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef0/6663979/8a0d3284572d/fimmu-10-01567-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef0/6663979/02e0853bcfcd/fimmu-10-01567-g0002.jpg

相似文献

1
Natural Clearance of Prolonged VDPV Infection in a Child With Primary Immunodeficiency Disorder.原发性免疫缺陷病患儿中延长 VDPV 感染的自然清除。
Front Immunol. 2019 Jul 23;10:1567. doi: 10.3389/fimmu.2019.01567. eCollection 2019.
2
Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication.免疫缺陷相关的疫苗衍生脊髓灰质炎病毒(iVDPV)病例:一项系统综述及对脊髓灰质炎根除的影响
Vaccine. 2015 Mar 3;33(10):1235-42. doi: 10.1016/j.vaccine.2015.01.018. Epub 2015 Jan 16.
3
New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.免疫缺陷相关疫苗衍生脊髓灰质炎病毒感染的病理生理学新见解;对超过 50 年数据的系统回顾。
Vaccine. 2018 Mar 20;36(13):1711-1719. doi: 10.1016/j.vaccine.2018.02.059. Epub 2018 Feb 23.
4
Vaccine-Derived Poliovirus Infection among Patients with Primary Immunodeficiency and Effect of Patient Screening on Disease Outcomes, Iran.原发性免疫缺陷患者中的疫苗衍生脊灰病毒感染及患者筛查对疾病结局的影响,伊朗。
Emerg Infect Dis. 2019 Nov;25(11):2005-2012. doi: 10.3201/eid2511.190540.
5
The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases.2 型疫苗衍生脊髓灰质炎病毒在原发性免疫缺陷病个体中的分子进化。
Viruses. 2021 Jul 20;13(7):1407. doi: 10.3390/v13071407.
6
The feasibility of identifying children with primary immunodeficiency disorders: preparation for the polio post-eradication era in Bangladesh.鉴定原发性免疫缺陷疾病患儿的可行性:为孟加拉国消灭脊髓灰质炎后时代做准备。
Vaccine. 2012 Aug 3;30(36):5396-400. doi: 10.1016/j.vaccine.2012.06.017. Epub 2012 Jun 19.
7
Case report: Clearance of longstanding, immune-deficiency-associated, vaccine-derived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection.病例报告:在慢性 SARS-CoV-2 感染的瑞德西韦治疗后,清除了长期存在的、免疫缺陷相关的、疫苗衍生的脊髓灰质炎病毒感染。
Front Immunol. 2023 Mar 3;14:1135834. doi: 10.3389/fimmu.2023.1135834. eCollection 2023.
8
Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India.印度原发性免疫缺陷疾病患儿中的脊髓灰质炎病毒排泄情况。
Emerg Infect Dis. 2017 Oct;23(10):1664-1670. doi: 10.3201/eid2310.170724.
9
Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.疫苗衍生脊髓灰质炎病毒与原发性免疫缺陷儿童,伊朗,1995 - 2014年
Emerg Infect Dis. 2016 Oct;22(10):1712-9. doi: 10.3201/eid2210.151071.
10
Screening for long-term poliovirus excretion among children with primary immunodeficiency disorders: preparation for the polio posteradication era in Bangladesh.对原发性免疫缺陷病患儿进行长期脊髓灰质炎病毒排泄筛查:为孟加拉国消除脊髓灰质炎后时代做准备。
J Infect Dis. 2014 Nov 1;210 Suppl 1:S373-9. doi: 10.1093/infdis/jiu221.

引用本文的文献

1
Excretion and clearance of Sabin-like type 3 poliovirus in a child diagnosed with severe combined immunodeficiency.一名被诊断为重症联合免疫缺陷的儿童体内萨宾3型脊髓灰质炎病毒的排泄与清除情况
Hum Vaccin Immunother. 2025 Dec;21(1):2484882. doi: 10.1080/21645515.2025.2484882. Epub 2025 Apr 2.
2
Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Infections: A Review of Epidemiology and Progress in Detection and Management.免疫缺陷相关疫苗衍生脊髓灰质炎病毒(iVDPV)感染:流行病学及检测与管理进展综述
Pathogens. 2024 Dec 20;13(12):1128. doi: 10.3390/pathogens13121128.
3
Antiviral Development for the Polio Endgame: Current Progress and Future Directions.

本文引用的文献

1
Clearing Vaccine-Derived Poliovirus Infection Following Hematopoietic Stem Cell Transplantation: a Case Report and Review of Literature.造血干细胞移植后清除疫苗衍生脊髓灰质炎病毒感染:病例报告及文献复习。
J Clin Immunol. 2018 Jul;38(5):610-616. doi: 10.1007/s10875-018-0521-z. Epub 2018 Jun 14.
2
New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.免疫缺陷相关疫苗衍生脊髓灰质炎病毒感染的病理生理学新见解;对超过 50 年数据的系统回顾。
Vaccine. 2018 Mar 20;36(13):1711-1719. doi: 10.1016/j.vaccine.2018.02.059. Epub 2018 Feb 23.
3
脊髓灰质炎终结阶段的抗病毒药物研发:当前进展与未来方向
Pathogens. 2024 Nov 6;13(11):969. doi: 10.3390/pathogens13110969.
4
Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Excretion in an Infant with Severe Combined Immune Deficiency with Spillover to a Parent.一名患有严重联合免疫缺陷的婴儿排出与免疫缺陷相关的疫苗衍生脊髓灰质炎病毒(iVDPV)并传播给其父母。
Vaccines (Basel). 2024 Jul 9;12(7):759. doi: 10.3390/vaccines12070759.
5
Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR-WHO Collaborative Study Phase-I.印度原发性免疫缺陷患者肠道病毒排泄情况评估及疫苗衍生脊髓灰质炎病毒鉴定:印度医学研究理事会-世界卫生组织合作研究第一阶段成果
Vaccines (Basel). 2023 Jul 6;11(7):1211. doi: 10.3390/vaccines11071211.
6
Poliovirus surveillance in patients with primary immunodeficiencies, India.印度原发性免疫缺陷病患者的脊髓灰质炎病毒监测。
Bull World Health Organ. 2023 May 1;101(5):346-354. doi: 10.2471/BLT.22.289066.
7
Clinical, Immunological, and Molecular Features of Severe Combined Immune Deficiency: A Multi-Institutional Experience From India.严重联合免疫缺陷的临床、免疫学和分子特征:来自印度的多机构经验。
Front Immunol. 2021 Feb 8;11:619146. doi: 10.3389/fimmu.2020.619146. eCollection 2020.
8
Updated modelling of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters.免疫缺陷相关长期疫苗衍生脊髓灰质炎病毒(iVDPV)排出者流行率的更新建模。
Epidemiol Infect. 2019 Oct 24;147:e295. doi: 10.1017/S095026881900181X.
Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication.
原发性免疫缺陷患者是脊髓灰质炎病毒的储存宿主,对根除脊髓灰质炎构成风险。
Front Immunol. 2017 Jun 13;8:685. doi: 10.3389/fimmu.2017.00685. eCollection 2017.
4
Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India.印度原发性免疫缺陷疾病患儿中的脊髓灰质炎病毒排泄情况。
Emerg Infect Dis. 2017 Oct;23(10):1664-1670. doi: 10.3201/eid2310.170724.
5
Polio vaccines: WHO position paper, March 2016-recommendations.脊髓灰质炎疫苗:世界卫生组织立场文件,2016年3月 - 建议
Vaccine. 2017 Mar 1;35(9):1197-1199. doi: 10.1016/j.vaccine.2016.11.017. Epub 2016 Nov 25.
6
Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.疫苗衍生脊髓灰质炎病毒与原发性免疫缺陷儿童,伊朗,1995 - 2014年
Emerg Infect Dis. 2016 Oct;22(10):1712-9. doi: 10.3201/eid2210.151071.
7
Progress Toward Polio Eradication - Worldwide, 2015-2016.迈向消灭脊灰的进展——全世界,2015-2016 年。
MMWR Morb Mortal Wkly Rep. 2016 May 13;65(18):470-3. doi: 10.15585/mmwr.mm6518a4.
8
Standardized Methods for Detection of Poliovirus Antibodies.脊髓灰质炎病毒抗体检测的标准化方法。
Methods Mol Biol. 2016;1387:145-76. doi: 10.1007/978-1-4939-3292-4_8.
9
The 2015 IUIS Phenotypic Classification for Primary Immunodeficiencies.2015年国际免疫学会原发性免疫缺陷病表型分类
J Clin Immunol. 2015 Nov;35(8):727-38. doi: 10.1007/s10875-015-0198-5. Epub 2015 Oct 7.
10
An economic analysis of poliovirus risk management policy options for 2013-2052.2013 - 2052年脊髓灰质炎病毒风险管理政策选项的经济分析
BMC Infect Dis. 2015 Sep 24;15:389. doi: 10.1186/s12879-015-1112-8.